Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2018 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?

  • Authors:
    • Yu‑Dong Xiao
    • Cong Ma
    • Jun Liu
    • Hua‑Bing Li
    • Shun‑Ke Zhou
    • Zi‑Shu Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, The Second XiangYa Hospital of Central South University, Changsha, Hunan 410011, P.R. China
  • Pages: 3133-3139
    |
    Published online on: January 17, 2018
       https://doi.org/10.3892/etm.2018.5760
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Gadoxetic acid (Gd-EOB-DTPA) is a hepatocyte-specific magnetic resonance (MR) contrast agent, which has been increasingly used in recent years. However, it has been reported that Gd‑EOB‑DTPA related transient severe motion (TSM) is sometimes observed during the hepatic arterial phase of MR imaging, which may influence image quality. Since the hepatic arterial phase of contrast enhancement is used for the diagnosis of hepatocellular carcinoma, it is crucial to obtain a decent arterial phase imaging. The present study analyzed motion in patients receiving Gd‑EOB‑DTPA, comparing a single arterial phase acquisition to a five arterial phase acquisition to determine whether the multiphase acquisition was able to alleviate the TSM‑related hepatic arterial MR imaging artifact. It was demonstrated that the single‑phase acquisition failed to provide adequate diagnostic image quality in patients with TSM, whereas the multiphase arterial acquisition provided acceptable image quality in 20/22 (90.9%) patients with TSM. In conclusion, the results of the present study demonstrated that multiphase arterial acquisition is superior to single‑phase arterial acquisition, mitigating arterial MR imaging artifacts caused by TSM after the administration of Gd-EOB-DTPA.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Nishie A, Kakihara D, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Shimamoto D, Shirabe K, Hida T and Honda H: Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: Clinical impact of dual-source parallel radiofrequency excitation. Clin Radiol. 70:254–261. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, Teufel A, Stroszczynski C, Evert M and Wiggermann P: Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci Rep. 5:154082015. View Article : Google Scholar : PubMed/NCBI

3 

Esterson YB, Flusberg M, Oh S, Mazzariol F, Rozenblit AM and Chernyak V: Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: Associated clinical and imaging factors. Clin Radiol. 70:723–729. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, Schreyer AG, Stroszczynski C and Wiggermann P: MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep. 4:56212014. View Article : Google Scholar : PubMed/NCBI

5 

Hwang J, Kim YK, Jeong WK, Choi D, Rhim H and Lee WJ: Nonhypervascular hypointense nodules at gadoxetic acid-enhanced MR imaging in chronic liver disease: Diffusion-weighted imaging for characterization. Radiology. 276:137–146. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Tse JR, Naini BV, Lu DS and Raman SS: Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 279:118–127. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Xiao YD, Paudel R, Liu H, Zhang B, Ma C and Zhou SK: Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: A potential utility for the evaluation of regional liver function impairment following transcatheter arterial chemoembolization. Oncol Lett. 9:1191–1196. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Kubota K, Tamura T, Aoyama N, Nogami M, Hamada N, Nishioka A and Ogawa Y: Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma. Oncol Lett. 3:990–994. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Tamada T, Ito K, Sone T, Kanki A, Sato T and Higashi H: Gd-EOB-DTPA enhanced MR imaging: Evaluation of biliary and renal excretion in normal and cirrhotic livers. Eur J Radiol. 80:e207–e211. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Xiao YD, Paudel R, Liu J, Ma C, Zhang ZS and Zhou SK: MRI contrast agents: Classification and application (Review). Int J Mol Med. 38:1319–1326. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Haradome H, Grazioli L, Al Manea K, Tsunoo M, Motosugi U, Kwee TC and Takaraha T: Gadoxetic acid disodium-enhanced hepatocyte phase MRI: Can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging. 35:132–139. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE and Choi JY: Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 255:459–466. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Xiao YD, Ma C, Liu J, Li HB, Zhang ZS and Zhou SK: Evaluation of hypointense liver lesions during hepatobiliary phase MR imaging in normal and cirrhotic livers: Is increasing flip angle reliable? Sci Rep. 6:189422016. View Article : Google Scholar : PubMed/NCBI

14 

Aran S, Shaqdan KW and Abujudeh HH: Adverse allergic reactions to linear ionic gadolinium-based contrast agents: Experience with 194, 400 injections. Clin Radiol. 70:466–475. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PSC, Maturen KE, Chenevert TL and Hussain HK: Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: Effect on arterial phase image quality. Radiology. 266:452–461. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Li H, Xiao Y, Wang S, Li Y, Zhong X, Situ W, Xiao E and Zhang Z: TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA. Clin Radiol. 72:800 e1–800.e6. 2017. View Article : Google Scholar

17 

Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S and Hussain HK: Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol. 203:796–802. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Fujinaga Y, Ueda H, Kitou Y, Tsukahara Y, Sugiyama Y and Kadoya M: Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo. Jpn J Radiol. 31:166–171. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Michaely HJ, Morelli JN, Budjan J, Riffel P, Nickel D, Kroeker R, Schoenberg SO and Attenberger UI: CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE): A new technique for fast time-resolved dynamic 3-dimensional imaging of the abdomen with high spatial resolution. Invest Radiol. 48:590–597. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Yoo JL, Lee CH, Park YS, Kim JW, Lee J, Kim KA, Seol HY and Park CM: The short breath-hold technique, controlled aliasing in parallel imaging results in higher acceleration, can be the first step to overcoming a degraded hepatic arterial phase in liver magnetic resonance imaging: A prospective randomized control study. Invest Radiol. 51:440–446. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK and Jaffe TA: Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology. 274:141–148. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Hayashi T, Saitoh S, Tsuji Y, Takahashi J, Tagaya N, Hiramoto M, Fukuzawa K, Tano M, Miyati T and Kumada H: Influence of gadoxetate disodium on oxygen saturation and heart rate during dynamic contrast-enhanced MR imaging. Radiology. 276:756–765. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Motosugi U, Bannas P, Bookwalter CA, Sano K and Reeder SB: An investigation of transient severe motion related to gadoxetic acid-enhanced MR imaging. Radiology. 279:93–102. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Haradome H, Grazioli L, Tsunoo M, Tinti R, Frittoli B, Gambarini S, Morone M, Motosugi U and Colagrande S: Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging? J Magn Reson Imaging. 32:334–340. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Pietryga JA, Burke LMB, Marin D, Jaffe TA and Bashir MR: Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: Examination recovery with a multiple arterial phase acquisition. Radiology. 271:426–434. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Fujinaga Y, Ohya A, Tokoro H, Yamada A, Ueda K, Ueda H, Kitou Y, Adachi Y, Shiobara A, Tamaru N, et al: Radial volumetric imaging breath-hold examination (VIBE) with k-space weighted image contrast (KWIC) for dynamic gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI of the liver: Advantages over cartesian VIBE in the arterial phase. Eur Radiol. 24:1290–1299. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Budjan J, Ong M, Riffel P, Morelli JN, Michaely HJ, Schoenberg SO and Haneder S: CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid. Eur J Radiol. 83:2007–2012. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Kazmierczak PM, Theisen D, Thierfelder KM, Sommer WH, Reiser MF, Notohamiprodjo M and Nikolaou K: Improved detection of hypervascular liver lesions with CAIPIRINHA-Dixon-TWIST-volume-interpolated breath-hold examination. Invest Radiol. 50:153–160. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Gutzeit A, Matoori S, Froehlich JM, von Weymarn C, Reischauer C, Kolokythas O, Goyen M, Hergan K, Meissnitzer M, Forstner R, et al: Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol. 26:2714–2722. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xiao YD, Ma C, Liu J, Li HB, Zhou SK and Zhang ZS: Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?. Exp Ther Med 15: 3133-3139, 2018.
APA
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., & Zhang, Z. (2018). Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?. Experimental and Therapeutic Medicine, 15, 3133-3139. https://doi.org/10.3892/etm.2018.5760
MLA
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., Zhang, Z."Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?". Experimental and Therapeutic Medicine 15.3 (2018): 3133-3139.
Chicago
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., Zhang, Z."Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?". Experimental and Therapeutic Medicine 15, no. 3 (2018): 3133-3139. https://doi.org/10.3892/etm.2018.5760
Copy and paste a formatted citation
x
Spandidos Publications style
Xiao YD, Ma C, Liu J, Li HB, Zhou SK and Zhang ZS: Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?. Exp Ther Med 15: 3133-3139, 2018.
APA
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., & Zhang, Z. (2018). Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?. Experimental and Therapeutic Medicine, 15, 3133-3139. https://doi.org/10.3892/etm.2018.5760
MLA
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., Zhang, Z."Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?". Experimental and Therapeutic Medicine 15.3 (2018): 3133-3139.
Chicago
Xiao, Y., Ma, C., Liu, J., Li, H., Zhou, S., Zhang, Z."Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?". Experimental and Therapeutic Medicine 15, no. 3 (2018): 3133-3139. https://doi.org/10.3892/etm.2018.5760
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team